Clinical Trial Update: Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 pilot study evaluating pentoxifylline for hepatopulmonary syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatopulmonary Syndrome

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Hepatopulmonary Syndrome | Phase 1 | Status: TERMINATED